Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | TGTX | RGEN | ||
| Company | Blueprint Medicines Corp | Tg Therapeutics | Repligen Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 129.35 | 53.97 | 143.98 | ||
| High | 129.55 | 56.74 | 147.59 | ||
| Low | 129.30 | 53.68 | 143.98 | ||
| Latest | 129.46 | 55.83 | 147.01 | ||
| Change | +0.18 | +2.20 | +1.78 | ||
| % Change | +0.14% | +4.10% | +1.23% | ||
| Volume | 2,980,900 | 6,852,200 | 1,966,200 | ||
| 20-Day Average Volume | 4,470,280 | 3,058,755 | 1,063,565 | ||
| Previous Close | 129.28 | 53.63 | 145.23 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 128.60 | 46.91 | 130.03 | ||
| 20-Day Raw Stochastic | 88.49% | 92.60% | 93.52% | ||
| 20-Day Relative Strength | 73.17 | 79.18 | 66.86 | ||
| Weighted Alpha | +17.08 | +75.41 | +19.70 | ||
| Today's Opinion | 100% Buy | 100% Buy | 24% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 07/10/25 | +4.90% since 06/18/26 | +11.35% since 06/18/26 | ||
| Low | 129.00 on 07/11/25 | 52.70 on 06/23/26 | 124.85 on 06/23/26 | ||
| High | 129.65 on 07/16/25 | 57.38 on 06/22/26 | 149.05 on 06/25/26 | ||
| 1-Month | |||||
| %Chg | +0.96% since 06/17/25 | +40.52% since 05/26/26 | +27.62% since 05/26/26 | ||
| Low | 128.00 on 06/20/25 | 36.47 on 06/02/26 | 112.00 on 05/27/26 | ||
| High | 129.65 on 07/16/25 | 57.38 on 06/22/26 | 149.05 on 06/25/26 | ||
| 3-Month | |||||
| %Chg | +52.86% since 04/17/25 | +74.58% since 03/26/26 | +28.48% since 03/26/26 | ||
| Low | 83.27 on 04/22/25 | 31.31 on 03/27/26 | 100.99 on 05/14/26 | ||
| High | 129.65 on 07/16/25 | 57.38 on 06/22/26 | 149.05 on 06/25/26 | ||
| 6-Month | |||||
| %Chg | +17.64% since 01/17/25 | +81.44% since 12/26/25 | -11.55% since 12/26/25 | ||
| Low | 73.04 on 04/09/25 | 26.76 on 03/12/26 | 100.99 on 05/14/26 | ||
| High | 129.65 on 07/16/25 | 57.38 on 06/22/26 | 175.77 on 01/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,360,786 | 8,546,679 | 8,292,540 | ||
| Shares Outstanding, K | 64,582 | 153,084 | 56,408 | ||
| Annual Sales | 508,820,000 | 616,290,000 | 738,260,000 | ||
| Annual Net Income | -67,090,000 | 447,180,000 | 48,890,000 | ||
| Last Quarter Sales | 149,410,000 | 204,920,000 | 194,260,000 | ||
| Last Quarter Net Income | 500,000 | 19,780,000 | 8,330,000 | ||
| 60-Month Beta | 0.89 | 1.68 | 1.09 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.74 on 05/01/25 | 0.17 on 05/06/26 | 0.48 on 05/05/26 | ||
| Earnings Date | 08/07/25 | 08/03/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.43 | 80.68 | ||